Free Trade Agreements (FTAs) aim to increase global trade and promote economic growth and historically, this has led to improved population health. However, this link is now weakening and attention is being focused instead on the effect of FTAs on health and the ability of governments to mitigate against any negative impacts. The London School […]
TTIP and Public Health Read More »
An important chapter of the Transatlantic Trade and Investment Partnership (TTIP) trade negotiations between the EU and US deals with ’Regulatory Cooperation’. Whilst it may sound dull and harmless it poses and extremely serious threat to national governments’ right to regulate, for example to protect public health, consumer rights, workers or the environment. the European
Public health concerns over TTIP Read More »
The European Parliament has made recommendations about the TTIP negotiations that include vital safeguards for public health and send a clear signal that the controversial Investor-to-State Dispute Settlement system (ISDS) must be reformed. As the European Parliament will have a final say on TTIP, it is crucial that MEPs have set down some red lines
Transatlantic Trade and Investment Partnership (TTIP) Read More »
The European Commission has published its analysis of some 150,000 replies to an online consultation on investment protection and investor-to-state dispute settlement (ISDS) in the Transatlantic Trade and Investment Partnership (TTIP). A key question in the consultation was whether the EU’s proposed approach for TTIP would achieve the right balance between protecting investors and safeguarding the
The European Commission has published the EU’s proposals for legal text in the Transatlantic Trade and Investment Partnership (TTIP) it is negotiating with the US. This is the first time the Commission has made public such proposals in bilateral trade talks and reflects its commitment to greater transparency in the negotiations. These texts set out the
Details about the proposed EU/US TTIP Read More »
A new directive on trade secrets being produced by the European Commission is strongly criticized by the European Public Health Alliance (EPHA). They are particularly concerned that: it contains an unreasonably broad definition of ‘trade secrets’ it offers overly-broad protection for companies there are inadequate safeguards to ensure consumers, journalists and researchers have reliable access to
Problems with the directive on trade secrets Read More »
